TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.

Marijn Lijffijt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.